Meet with Frazier Healthcare Partners
San Diego, CA
10:30am - 12:00pm
With over 26 years of exclusively investing in over 170 healthcare companies, Frazier Healthcare Partners has a great deal of experience building successful life science businesses. On May 8, 2018, Jamie Brush MD, and Patrick Heron, MBA will be visiting JLABS in San Diego to provide an overview of Frazier Healthcare Partners’ unique investment strategies and meet 1-on-1 with pre-selected companies.
Frazier Healthcare Partners is committed to helping great healthcare companies who are working hard to make a difference in the future of life sciences. The firm has partnered with exceptional entrepreneurs at all stages and focuses on therapeutic development. With $3 billion under management, investments in over 170 companies and 35 IPOs, Frazier Healthcare Partners has built a team with deep knowledge and scientific expertise that enables company building.
Jamie Brush, MD and Patrick Heron, MBA will be in attendance to provide an overview presentation of the firm’s areas of interest. They will be on hand to meet with a handful of applicants 1-on-1 after the presentation. To be considered for a 1-on-1 meeting, please complete the information required here. Applications due by April 9, 2018.
Frazier Participating Representatives:
Jamie W. Brush | Vice President, Frazier Healthcare Partners read bio»
Patrick Heron | Managing General Partner, Frazier Healthcare Partners read bio»
10:30AM | Registration Opens and Networking
11:00AM | Presentation, Q&A
12:00PM | Lunch and Networking
1:00PM | One-on-one Meetings
5:00PM | Program Close
*Companies must have applied for a one-on-one meeting ahead of time and been approved. Applications are due April 9th. Apply Here.
$25 | General Public
$35 | At the Door
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Pre-registration to attend the presentation, Q&A, and lunch will remain open until May 8th (or sold out).
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time. The one-on-one application period will close on April 8, 2018. Your application will be reviewed and you will be notified of acceptance by April 25, 2018. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved.
JLABS in San Diego
3210 Merryfield Row
San Diego, CA
James W. Brush, M.D. | Vice President, Frazier Healthcare Partners
Jamie joined Frazier Healthcare Partners in 2016 and focuses on investment identification, due diligence, and deal closing. Before joining Frazier, Jamie was a management consultant with the Boston Consulting Group, where he was a core member of the Healthcare Practice. In this capacity, he led projects involving Biotechnology mergers and acquisitions, R&D, manufacturing and business development strategy. Jamie received his M.D. from the University of Southern California, where he was inducted into Alpha Omega Alpha honors society, and his B.A. from Middlebury College. He completed his postgraduate training in Internal Medicine at Beth Israel Deaconess Medical Center in Boston. He has co-authored several papers in top-tier journals on genomic instability and its role in cancer, and is a member of the board of directors of Longwood Symphony Orchestra.
Connect with James: Connect on LinkedIn
^ Back to Speakers’ list ^
Patrick Heron | Senior Associate, Frazier Healthcare Partners
Patrick is a Managing General Partner of Frazier’s Life Sciences team. He joined the firm in 1999 and opened Frazier’s Menlo Park office in 2003. Throughout his 12 years as General Partner, Patrick has led or co-led investments across nearly 20 companies. Patrick has successfully partnered with entrepreneurs across a range of company types and stages, from early – stage anti-infectives companies to >$100M commercial-stage dermatology companies. Patrick has also been active in company formation around both early – and later – stage assets. He has led and served as director for many successful Frazier Life Sciences investments, including Tobira Therapeutics (acquired by Valeant), MedPointe (acquired by Meda), and Collegium (NASDAQ: COLL). He currently serves on the boards of Imago BioSciences, Iterum Therapeutics, Silvergate Pharmaceuticals, SutroVax and Zavante Therapeutics.
Prior to joining Frazier, Patrick helped develop McKinsey & Company’s West Coast biotechnology consulting practices, where he led projects involving mergers and acquisitions, product launches, sales force optimization, corporate partnering, and research prioritization. Patrick received his M.B.A. from Harvard Business School. He also holds a B.A. from the University of North Carolina at Chapel Hill, where he is a Phi Betta Kappa graduate and Morehead Scholar.
Connect with Patrick: Connect on LinkedIn
^ Back to Speakers’ list ^
About the Meet with…Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, Mercury Fund, DARPA’s Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCI, NCATS, NINDS, Allegory Venture Partners, Clarus Ventures, Johnson & Johnson Innovation, California Institute for Regenerative Medicine, Astellas Venture Management, and OrbiMed.
Contact: Michelle Maiello
Contact Email: firstname.lastname@example.org